Hugel Aesthetics

Founded in 2001, Hugel is a South Korea–based global leader in medical aesthetics, specializing in the development and commercialization of botulinum toxin, hyaluronic acid fillers, skin boosters, threads, and biocosmetics. Over the past two decades, Hugel has built a strong global footprint, with commercial presence in approximately 70 countries and operations across nine international subsidiaries. Leveraging strong global momentum, Hugel Aesthetics was formed as the Company's dedicated North American business unit, established to lead commercialization in the United States, Canada, and Australia. Backed by Hugel's global scale and expertise, Hugel Aesthetics is a well-resourced, growth-oriented organization focused on expanding access to Letybo and establishing a strong, long-term presence in medical aesthetics.